From May 11 to 15, 2025, the 22nd International Congress of Cytology (ICC) was held in Florence, Italy—a historic city rich in cultural heritage. Organized by the International Academy of Cytology (IAC), this prestigious event has been convened every three years since its inception in 1957. It serves as a premier platform for scientists, physicians, and professionals from around the world to exchange ideas and advance the field of cytology. Landing Med, a leading enterprise in cytological AI innovation, was invited to participate and showcased its outstanding achievements and innovation capabilities in AI-powered cytology, including its advanced all-in-one portable digital pathology slide scanner.
Ms. Sun Xiaorong, Chairwoman of Landing Med, delivers two speeches at ICC 2025
At the conference, Ms. Sun Xiaorong, Chairwoman of Landing Med, delivered two important speeches, in which she emphasized the core concept of "AI-powered cytology diagnostics to advance the accessibility of cervical cancer screening." She highlighted Landing Med's unique strengths in big data, presenting a high-quality, efficient, widely accessible, low-cost, and user-friendly solution from China to help reduce global cancer incidence and mortality. Her remarks showcased the company's technological capabilities and international vision on AI cervical cancer screening.
As the builder of the world's largest AI-powered cloud platform for digital cervical cancer pathology, a key provider of large-scale free cervical cancer screening technology, and a contributor to the establishment of Asia's AI screening standards, Landing Med has achieved remarkable milestones in the field of cervical cancer diagnostics, supported by innovations such as their high throughput cytology slide scanner. Dr. Sun's presentations were met with enthusiastic acclaim from international experts, many of whom praised the company's ability to harness big data in developing efficient and precise AI diagnostic models.
Professor Yosep Chong from The Catholic University of Korea discusses Landing Med's thyroid AI system
During the technical sessions, Professor Yosep Chong, a pathology expert from The Catholic University of Korea, specifically acknowledged Landing Med's breakthroughs in AI-based thyroid diagnostics.
Professor Roberto Dina from Imperial College London also expressed strong admiration for Landing Med's achievements. He noted that the company's extensive clinical data analysis had enabled the development of a high-performance AI diagnostic system—setting a new benchmark for the global cytology field.
International partner showcases Landing Med AI system
Meanwhile, a well-established international medical technology company featured Landing Med's AI system prominently at its exhibition booth. Dr. Sun visited the booth and engaged in a meaningful and cordial exchange with the company's representatives.
As the 22nd International Congress of Cytology concluded successfully, Landing Med once again demonstrated its leadership and innovation in AI-driven cytology on the global stage. Looking ahead, the company remains committed to fostering international collaboration, accelerating the adoption of AI in cytological diagnostics, and safeguarding the health and well-being of patients around the world.
Other Landing Med's Digital Pathology Products You May Like
fr 
es 
CN
